Raily Aesthetic Medicine International Holdings (HKSE:02135) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings 5-Year EBITDA Growth Rate?

Raily Aesthetic Medicine International Holdings's EBITDA per Share for the six months ended in Jun. 2023 was HK$0.03.

During the past 12 months, Raily Aesthetic Medicine International Holdings's average EBITDA Per Share Growth Rate was -92.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -50.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Raily Aesthetic Medicine International Holdings was 0.40% per year. The lowest was -50.00% per year. And the median was -24.80% per year.

Competitive Comparison of Raily Aesthetic Medicine International Holdings's 5-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raily Aesthetic Medicine International Holdings's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's 5-Year EBITDA Growth Rate falls into.

Raily Aesthetic Medicine International Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Raily Aesthetic Medicine International Holdings (HKSE:02135) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Raily Aesthetic Medicine International Holdings 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN

Website

http://m.raily.com

Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.

Executives

Fu Haishu	2201 Interest of corporation controlled by you
Jin Chunmiao	2202 Interest of your spouse
Ruide Consultation Limited	2101 Beneficial owner
Youxin Management Co., Limited	2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines